Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,331,200 | 2,913,700 | 1,224,600 | 1,573,800 | 2,326,500 |
| Marketable Securities | 1,278,900 | 1,562,200 | 2,313,400 | 2,115,200 | 2,568,600 |
| Receivables | 1,913,800 | 1,880,500 | 1,958,500 | 1,787,000 | 1,441,600 |
| Inventories | 1,068,600 | 804,200 | 929,900 | 902,700 | 1,001,600 |
| Other current assets | 1,294,600 | 1,221,200 | 1,214,500 | 1,494,600 | 1,393,900 |
| TOTAL | $6,887,100 | $8,381,800 | $7,640,900 | $7,873,300 | $8,732,200 |
| Non-Current Assets | |||||
| PPE Net | 3,411,500 | 3,247,300 | 3,601,200 | 3,182,400 | 2,501,800 |
| Investments And Advances | 3,671,100 | 2,660,900 | 3,066,500 | 3,488,900 | 4,165,200 |
| Intangibles | 8,846,400 | 9,285,200 | 8,826,400 | 8,512,100 | 7,477,600 |
| Other Non-Current Assets | 1,802,800 | 3,659,100 | 2,153,900 | 595,900 | 0 |
| TOTAL | $17,731,800 | $18,852,500 | $17,648,000 | $15,779,300 | $14,144,600 |
| Total Assets | $24,618,900 | $27,234,300 | $25,288,900 | $23,652,600 | $22,876,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 454,900 | 530,800 | 370,500 | 395,500 | 279,800 |
| Accrued Expenses | 3,145,300 | 2,765,800 | 2,861,200 | 2,901,300 | 2,903,500 |
| TOTAL | $3,742,200 | $4,863,800 | $3,295,200 | $3,368,200 | $3,419,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,426,200 | 4,459,000 | 5,936,500 | 5,935,000 | 6,512,700 |
| Other Non-Current Liabilities | 1,671,700 | 1,761,600 | 1,346,101 | 1,497,700 | 729,600 |
| TOTAL | $10,190,600 | $9,031,400 | $8,962,101 | $7,686,300 | $7,328,300 |
| Total Liabilities | $13,932,800 | $13,895,200 | $12,257,300 | $11,054,500 | $10,748,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,336 | 174,064 | 196,709 | 211,563 | 215,952 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 13,976,300 | 16,455,400 | 16,257,000 | 15,810,400 | 15,071,600 |
| Other shareholders' equity | -313,300 | -139,400 | -248,500 | -333,200 | -331,100 |
| TOTAL | $10,686,100 | $13,339,100 | $13,031,600 | $12,598,100 | $12,128,600 |
| Total Liabilities And Equity | $24,618,900 | $27,234,300 | $25,288,900 | $23,652,600 | $22,876,800 |